Radium 223 Dichloride (Xofigo)®

Common name: Radium 223 Dichloride
Brand name: Xofigo®
 

What is Radium 223 Dichloride?


Radium 223 Dichloride is a radiopharmaceutical that is used to treat patients with castration-resistant prostate cancer which has spread to the bones, but has not spread to other organs in the body.
 

How is Radium 223 Dichloride administered?


Radium 223 Dichloride is administered by injection.
 

What are possible side effects of this treatment?


Everyone responds differently to treatments for bone metastases – some experience many side effects while others experience very few. Below are the most common side effects experienced by those who received radium 223 dichloride. Tell your health care team about side-effects you are experiencing so they know how best to help you manage them.
  • Nausea
  • Diarrhea
  • Vomiting
  • Swelling of the arms or legs
  • Low blood cell count
 

Is Radium 223 Dichloride covered in my province or territory?

Radium 223 Dichloride is covered by provincial drug programs in:
 
  • British Columbia (special authorization)
  • Manitoba
  • Ontario
  • Québec
  • Saskatchewan
 
Radium 223 Dichloride is not covered by provincial drug programs in:
 
  • Alberta
  • New Brunswick
  • Newfoundland & Labrador
  • Nova Scotia
  • Prince Edward Island
  • Nunavut
  • Northwest Territories
  • Yukon
Last Reviewed: April 2018

Prostate Cancer Awareness Month

Donate Now!


Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Prostate Cancer Canada launches first national program in radionuclide therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.
More

Honouring dad this Father’s Day the Canadian way: In plaid

TORONTO, ON – (May 8, 2018) – Plaid replaces business-casual on Friday, June 15 as hundreds of thousands of Canadians don the iconic Canadian attire all to honour dad and end prostate cancer.
More

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.
More


Click here for news archive